Pilar de la Rocha Mur/LinkedIn
Jul 11, 2026, 18:53
Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
Pilar de la Rocha Mur, Vice-President, Head of EMEA at BeOne Medicines, shared on LinkedIn:
”Trust is still the real currency in clinical research.
That was the theme that ran through the BeOne Medicines investigator meeting at EHA 2026 in Stockholm, and it’s one I keep coming back to.
Last night in Stockholm, I had the privilege of being in a room with some of Europe‘s leading hematology investigators.
Around 100 experts with one shared purpose: making clinical research better for patients.
What stayed with me the most was the quality of the conversation.
Here are my two takeaways from an evening that reminded me why this work matters.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 11, 2026, 21:00Rishdha Roshad: Intraoperative Cell Salvage – Turning Blood Loss into an Opportunity for Recovery
-
Oct 11, 2026, 20:59Anthony R. Sloan: Honored to Share Our Work at the 20th Midwest Platelet Conference
-
Oct 11, 2026, 20:55Vipin M. Vashishtha: Mild COVID-19 and Malaria Leave Measurable Fingerprints on the Clotting System
-
Oct 11, 2026, 16:57Shiny K. Kajal: Japan Advances Artificial Blood via Haemoglobin Vesicles Trials
-
Oct 11, 2026, 16:45Luca Scarcia: Rescue Stenting Superior When Posterior Circulation Thrombectomy Fails
-
Oct 11, 2026, 16:27Giuseppe Bellelli: Reevaluating Anticoagulation Net Benefit in Frail Older Adults
-
Oct 11, 2026, 16:17Johnathan Whetstine: How Does MYC Go From 2 Copies to an Amplified Oncogene?
-
Oct 11, 2026, 16:03Parth Parmar: Practical Guidelines for Managing Venous Thromboembolism
-
Oct 11, 2026, 15:31Muhammad Alvi: CASPR Study Explores Treatment Response Across ESUS Phenotypes